Our research focuses on developing and translating novel PET methods for the study of neurodevelopment and neuropsychiatric illness. This involves using PET methodologies to investigate neurochemical changes in the brain and studying novel radioligands to characterize neurotransmitter-protein interactions and how they are influenced by development, genes, environment and drugs. These imaging methods are being applied to investigate the etiologies and mechanisms in diseases such as Down syndrome, affective disorders, schizophrenia, Alzheimer’s disease and Tourette syndrome.
The PI of this project was: Bradley Christian, PhD
This project was funded by: NIH
The term of this project was: December 2016 to April 2017
The number of subjects scanned during this project was: 8